Below are some of its primary target concerns of this weight loss medication: Obesity and Overweight Conditions
All compounding takes place at a licensed pharmacy, complies with state boards, receives a valid Certificate of Analysis (COA), and is made at a FDA-registered facility
Recalls & Warnings November 29, 2012 Sensa Settles Second False Advertising Lawsuit On November 27, 2012, Sensa Products LLC, maker of the Sensa Weight Loss System, announced it agreed to settle a false advertising lawsuit filed by the Nutritional Supplemental Task Force in California, without an admission of guilt
doi: 10.1016/j.molbiopara.2009.12.011 10
In one trial, the condition occurred in 4% of those on Wegovy who had type 2 diabetes and overweight compared to 2.7% of the placebo group